About Neurovalens
Neurovalens is a company based in Belfast (United Kingdom) founded in 2013. Neurovalens has raised $26.12 million across 8 funding rounds from investors including British Business Bank, Invest Northern Ireland and MedTech Innovator. The company has 22 employees as of January 31, 2022. Neurovalens offers products and services including Modius Sleep and Stimulation Pads. Neurovalens operates in a competitive market with competitors including Noctrix Health, Brain in Hand, Zynex, Trexo Robotics and Neurofenix, among others.
- Headquarter Belfast, United Kingdom
- Employees 22 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neurovalens Limited
- Date of Incorporation 12 Apr, 2013
- Jurisdiction BALLYMENA, COUNTY ANTRIM, NORTHERN IRELAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$26.12 M (USD)
in 8 rounds
-
Latest Funding Round
$8.12 M (USD), Series A
Aug 19, 2025
-
Investors
British Business Bank
& 23 more
-
Employee Count
22
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neurovalens
Neurovalens offers a comprehensive portfolio of products and services, including Modius Sleep and Stimulation Pads.
FDA-cleared noninvasive device for treating chronic insomnia.
Replacement pads for neurostimulation devices to maintain treatment.
People of Neurovalens
Unlock access to complete
Unlock access to complete
Funding Insights of Neurovalens
Neurovalens has successfully raised a total of $26.12M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $8.12 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neurovalens
Neurovalens has secured backing from 24 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include British Business Bank, Invest Northern Ireland and MedTech Innovator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Acceleration of medical device, digital health, and diagnostic companies is facilitated worldwide.
|
Locked | Locked | Locked | |
|
Early-stage investments are provided by Techstart Ventures.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on angel investments
|
Locked | Locked | Locked |
Investor details for Neurovalens
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neurovalens
Investment portfolio details for Neurovalens
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neurovalens
Detailed financials for Neurovalens
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurovalens Comparisons
Peer comparison for Neurovalens
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neurovalens
Neurovalens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Noctrix Health, Brain in Hand, Zynex, Trexo Robotics and Neurofenix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable therapeutic devices for neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Assistive technology is developed for impaired executive brain functions.
|
|
| Locked | Locked | Locked |
Non-invasive electrotherapy and stroke rehabilitation devices are developed by Zynex.
|
|
| Locked | Locked | Locked |
Battery-operated exoskeletons for children with disabilities are developed.
|
|
| Locked | Locked | Locked |
Medical devices for neurorehabilitation are manufactured for therapy sessions.
|
Detailed competitors of Neurovalens
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurovalens
Complete news archive for Neurovalens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurovalens
Neurovalens was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Neurovalens is headquartered in Belfast, United Kingdom. It is registered at Belfast, Northern Ireland, United Kingdom.
Neurovalens is a funded company, having raised a total of $26.12M across 8 funding rounds to date.
As of Jan 31, 2022, the latest employee count at Neurovalens is 22.
Founded in 2013 in Belfast, United Kingdom, Neurovalens operates in the medical device sector, focusing on neuromodulation technology. A compact headset called Stimu Slim is being developed to target brain areas that suppress appetite and induce metabolic changes in the nervous system. The company addresses obesity through non-invasive interventions and was recognized as Company of the Year at the Invest NI Propel Programme awards.
Neurovalens's top competitors include Zynex, Noctrix Health and Brain in Hand.
Neurovalens offers Modius Sleep and Stimulation Pads.
Neurovalens has 24 investors. Key investors include British Business Bank, Invest Northern Ireland, MedTech Innovator, Techstart Ventures, and ACF Investors.